Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activations

The Canadian Cancer Trials Group recently activated two trials:

Canadian Cancer Trials Group CRC.6 (CALGB 80702) -- A Phase III Trial of 6 versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo For Patients With Resected Stage III Colon Cancer -- was centrally activated 28 March 2011.

http://www.ctg.queensu.ca/trials/gastro-intestinal/crc6/crc6.html

Canadian Cancer Trials Group IND.205 -- A Phase II Study of PX-866 in Patients With Metastatic Castration Resistant Prostate Cancer (CRPC) -- was centrally activated 4 April 2011.